GIGYF2变异与突触发育及孤独症谱系障碍的关联证据
该研究通过临床遗传学、条件性敲除小鼠模型、神经生物学与分子研究,发现GIGYF2的LGD或错义变异与ASD、语言问题、智力障碍和焦虑相关;Gigyf2 cKO小鼠表现出类似行为表型及突触稳态和IGF-1R/mTOR信号异常,药理学抑制mTOR或敲低Nrp2可 rescue 突触缺陷。
要点
- GIGYF2变异定义了一个新的ASD亚型,临床常见ASD、语言问题、智力障碍和焦虑。
- Gigyf2缺陷小鼠重现孤独症样行为、认知缺陷和焦虑样行为。
- IGF-1R/mTOR通路及Nrp2可能作为GIGYF2相关ASD的潜在治疗靶点。
核心结论
- GIGYF2变异与ASD、语言问题、智力障碍和焦虑相关,定义了一个新的ASD亚型。
- GIGYF2是突触发育和功能的关键调节因子,其功能障碍参与ASD发病。
- IGF-1R/mTOR通路是GIGYF2相关ASD亚型的潜在治疗靶点。
研究设计与样本
- 研究采用临床遗传学、条件性敲除小鼠模型、神经生物学和分子研究相结合的综合方法。
- 通过靶向测序、神经发育障碍队列的大规模基因组数据分析及国际合作,识别GIGYF2变异个体。
- 对16例携带GIGYF2变异的先证者进行临床特征分析。
主要发现
- 16例先证者常见特征包括ASD、语言问题、智力障碍和焦虑。
- Gigyf2 cKO小鼠表现出明显的孤独症样行为、认知缺陷和焦虑样行为,与受累个体表型相似。
- Gigyf2缺陷破坏突触稳态,表现为树突棘密度和微小兴奋性突触后电流改变。
- Gigyf2缺陷损害IGF-1R/mTOR信号,并导致Nrp2等突触相关基因失调。
- 用雷帕霉素或Torin1药理学抑制mTOR,以及敲低Nrp2,可挽救Gigyf2 KO神经元的突触缺陷。
关键数值与推荐
- 识别13例来自13个家系的受累个体携带新发错义变异。
- 临床特征分析纳入16例携带GIGYF2变异的先证者。
临床怎么用
- 对ASD伴语言问题、智力障碍和焦虑的个体,可考虑GIGYF2变异检测以明确遗传亚型。
- GIGYF2相关ASD亚型中,IGF-1R/mTOR通路及Nrp2可能作为潜在干预靶点,但尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Autism spectrum disorder (ASD) is a heterogeneous condition in which genetically defined subtypes offered insights into underlying biological mechanisms and potential targeted treatments. Here, we investigate the clinical and pathogenic significance of GIGYF2 variants in ASD through an integrated approach combining clinical genetics, conditional knockout (cKO) mouse models, neurobiology, and molecular studies. Through targeted sequencing, large-scale genomic data analysis of neurodevelopmental disorder cohorts, and international collaborations, we identified ten affected individuals from eight families harboring de novo or dominantly inherited likely gene-disruptive (LGD) variants and 13 affected individuals from 13 families with de novo missense variants in GIGYF2. Clinical characterization of 16 probands with GIGYF2 variants revealed common features, including ASD, language problems, intellectual disability, and anxiety. In a Gigyf2 cKO mouse model, we observed pronounced autistic-like behaviors, cognitive deficits, and anxiety-like behaviors, mirroring phenotypes observed in affected individuals. Mechanistically, Gigyf2 deficiency disrupted synaptic homeostasis, as evidenced by altered spine density and miniature excitatory postsynaptic currents, and impaired IGF-1R/mTOR signaling, along with dysregulation of synapse-related genes such as Nrp2. Pharmacological inhibition of mTOR with rapamycin or Torin1, as well as Nrp2 knockdown rescued synaptic defects in Gigyf2 KO neurons. These findings define a novel ASD subtype associated with GIGYF2 variants and establish GIGYF2 as a key regulator of synaptic development and function, implicating GIGYF2 dysfunction in ASD pathogenesis and highlighting the IGF-1R/mTOR pathway as a potential therapeutic target for GIGYF2-related ASD subtype.
引用
- Yu B, Zhu S, Xiao L, et al. Evidence supporting the role of GIGYF2 in synapse development and autism. Mol Psychiatry. 2026. PMID: 42297935. doi:10.1038/s41380-026-03681-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。